Your browser doesn't support javascript.
loading
Preclinical Effectiveness of Selective Inhibitor of IRS-1/2 NT157 in Osteosarcoma Cell Lines.
Garofalo, Cecilia; Capristo, Mariantonietta; Mancarella, Caterina; Reunevi, Hadas; Picci, Piero; Scotlandi, Katia.
Affiliation
  • Garofalo C; Experimental Oncology Laboratory, CRS Development of Biomolecular Therapies, Rizzoli Institute , Bologna , Italy.
  • Capristo M; Experimental Oncology Laboratory, CRS Development of Biomolecular Therapies, Rizzoli Institute , Bologna , Italy.
  • Mancarella C; Experimental Oncology Laboratory, CRS Development of Biomolecular Therapies, Rizzoli Institute , Bologna , Italy.
  • Reunevi H; TyrNovo Ltd. , Tel Aviv , Israel.
  • Picci P; Experimental Oncology Laboratory, CRS Development of Biomolecular Therapies, Rizzoli Institute , Bologna , Italy.
  • Scotlandi K; Experimental Oncology Laboratory, CRS Development of Biomolecular Therapies, Rizzoli Institute , Bologna , Italy.
Front Endocrinol (Lausanne) ; 6: 74, 2015.
Article in En | MEDLINE | ID: mdl-26029165
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Language: En Journal: Front Endocrinol (Lausanne) Year: 2015 Type: Article Affiliation country: Italy
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Language: En Journal: Front Endocrinol (Lausanne) Year: 2015 Type: Article Affiliation country: Italy